FDA product code QMD: Transcranial Magnetic Stimulation System For Smoking Cessation

QMD is the FDA product code for transcranial magnetic stimulation system for smoking cessation. It is a Class II device, regulated under 21 CFR 882.5802 and reviewed by the Neurology panel. FDA has cleared 2 510(k) submissions under QMD. The average 510(k) review took 130 days (median 130).

Definition

Intended for use as a transcranial magnetic stimulation system for neurological and psychiatric disorders and conditions.

Classification

FieldValue
Device nameTranscranial Magnetic Stimulation System For Smoking Cessation
Device classClass II
Regulation21 CFR 882.5802
Review panelNE — Neurology
Medical specialtyNeurology
Premarket route510(k)

510(k) clearances per year for QMD

YearClearancesAvg. review days
20201134
20211127

Top QMD applicants

ApplicantClearancesLatest
Brainsway , Ltd.22021-04-16

Most recent QMD clearances

510(k)ApplicantDeviceDecision dateReview days
K203616Brainsway , Ltd.Brainsway Deep (DTMS) System2021-04-16127
K200957Brainsway , Ltd.Brainsway Deep TMS System2020-08-21134

Recalls for QMD devices

openFDA lists no recalls for product code QMD.

Frequently asked questions

What is FDA product code QMD?

QMD is the FDA product code for transcranial magnetic stimulation system for smoking cessation. It is a Class II device, regulated under 21 CFR 882.5802 and reviewed by the Neurology panel.

What device class is QMD?

Class II, regulation 21 CFR 882.5802. Typical premarket route: 510(k).

How long does a 510(k) take for product code QMD?

Across 2 cleared submissions the average was 130 days from receipt to decision (median 130).

Which companies have the most QMD clearances?

Brainsway , Ltd. (2).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Neurology product codes · FDA product code lookup